Registry study for choosing a mitral valve treatment
Part of Heart & circulation clinical trials.
This study collects and compares real-world results to help doctors choose the best treatment for mitral valve “leakiness.” If you have clinically significant mitral insufficiency and have already had a specific heart procedure screening, your echocardiogram results may be used to understand outcomes over at least a month.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have clinically significant mitral insufficiency (a leaky mitral heart valve)
- You were already evaluated/screened for TMVI
- You have echocardiogram (ultrasound of the heart) results at the start
- Your records include echo after the TMVI procedure and after another timepoint (E2E and/or surgery), plus at least 30 days of follow-up
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study keeps a registry of adults who have a mitral valve problem and are being evaluated for a catheter-based mitral valve replacement. It helps doctors understand what treatments are used and how patients do.
This registry study follows people who are getting a minimally invasive heart valve repair called M-TEER. It helps doctors learn more about how well the procedure works and how patients recover.
This study looks at how long a new mitral valve treatment/device can stay working in people with moderate-to-severe or severe mitral valve leak. It may help avoid or delay surgery for people considered higher risk for mitral valve repair.
This study looks at how well CT scans and 3D echo (ultrasound) measure the mitral valve ring before surgery for severe mitral valve leakage. It may help doctors better plan valve repair.
This trial focuses on people with severe mitral valve narrowing or leaking who still have symptoms even after the best usual medications. It may help find better care and measure health outcomes when surgery is judged too risky or not suitable.
This study keeps track of people who had NeoChord treatment to help understand how well it works in everyday care. You may be included if you had a certain type of mitral valve leakage (regurgitation) and the procedure happened after 2016.
Hear when a new Mitral Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.